Ahmed Swidan, Gihan Hamdy Elsisi, Mohamed M. Ibrahim, Mohammad Aljazzar & Hossameldin Tawfik Sallam (2023) Projecting the potential cost-effectiveness of dapagliflozin for chronic kidney disease in Kuwait, Journal of Medical Economics, 26:1, 271-282, DOI: 10.1080/13696998.2023.2174749 Elsisi GH, Afify A, Abgad A, Zakaria I, Nasif N, Ibrahim HN, Raafat N, Carapinha JL.(2022) A budget impact analysis...
